Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
Tóm tắt
Từ khóa
Tài liệu tham khảo
Angiolillo, 1995, Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo, J. Exp. Med., 182, 155, 10.1084/jem.182.1.155
Cao, 1995, Gro-beta, a C-X-C chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice, J. Exp. Med., 182, 2069, 10.1084/jem.182.6.2069
Cao, 1996, Kringle domains of human angiostatin, J. Biol. Chem., 271, 29461, 10.1074/jbc.271.46.29461
Chen, 1995, A strategy to discover circulating angiogenesis inhibitors generated by human tumors, Cancer Res., 55, 4230
Clapp, 1993, The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis, Endocrinology, 133, 1292, 10.1210/endo.133.3.7689950
Dameron, 1994, Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1, Science, 265, 1582, 10.1126/science.7521539
Folkman, 1985, Angiogenesis and its inhibitors, 42
Folkman, 1989, What is the evidence that tumors are angiogenesis dependent?, J. Natl. Cancer Inst., 82, 4, 10.1093/jnci/82.1.4
Folkman, 1979, Long-term culture of capillary endothelial cells, Proc. Natl. Acad. Sci. USA, 76, 5217, 10.1073/pnas.76.10.5217
Gately, 1996, Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin, Cancer Res., 56, 4887
Gavrieli, 1992, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J. Cell Biol., 119, 493, 10.1083/jcb.119.3.493
Good, 1990, A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin, Proc. Nat. Acad. Sci. USA., 87, 6624, 10.1073/pnas.87.17.6624
Grant, 1989, Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro, Cell, 58, 933, 10.1016/0092-8674(89)90945-8
Gross, 1983, Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro, Proc. Natl. Acad. Sci. USA, 80, 2623, 10.1073/pnas.80.9.2623
Gupta, 1995, A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4, Proc. Natl. Acad. Sci. USA, 92, 7799, 10.1073/pnas.92.17.7799
Homandberg, 1985, Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth, Am. J. Path., 120, 327
Hori, 1991, Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor, Cancer Res., 51, 6180
Kandel, 1991, Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma, Cell, 66, 1095, 10.1016/0092-8674(91)90033-U
Kim, 1993, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo, Nature, 362, 841, 10.1038/362841a0
Maione, 1990, Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides, Science, 247, 77, 10.1126/science.1688470
Millauer, 1994, Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant, Nature, 367, 576, 10.1038/367576a0
Muragaki, 1995, Mouse col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones, Proc. Natl. Acad. Sci. USA, 92, 8763, 10.1073/pnas.92.19.8763
Nelson, 1995, Murine epidermal growth factor (EGF) fragment (33–42) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis, Cancer Res., 55, 3772
Nguyen, 1994, Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane, Microvascular Res., 47, 31, 10.1006/mvre.1994.1003
Obeso, 1990, A hemangioendothelioma-derived cell line, Lab. Invest., 63, 259
Oh, 1994, Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins, Proc. Natl. Acad. Sci. USA, 91, 4229, 10.1073/pnas.91.10.4229
O'Reilly, 1996, Angiostatin induces and sustains dormancy of human primary tumors in mice, Nature Med., 2, 689, 10.1038/nm0696-689
Parangi, 1996, Antiangiogenic therapy of transgenic mice impairs de novo tumor growth, Proc. Natl. Acad. Sci. USA, 93, 2002, 10.1073/pnas.93.5.2002
Rastinejad, 1989, Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene, Cell, 56, 345, 10.1016/0092-8674(89)90238-9
Rehn, 1994, a1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen, Proc. Natl. Acad. Sci. USA, 91, 4234, 10.1073/pnas.91.10.4234
Rehn, 1995, Identification of three N-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts, J. Biol. Chem., 270, 4705, 10.1074/jbc.270.9.4705
Sage, 1995, Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca (2+)-binding EF-hand sequence, J. Cell Biochem., 57, 127, 10.1002/jcb.240570113
Sakamato, 1991, Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2, Cancer Res., 51, 903
Strieter, 1995, Human interferon-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis, Biochem. Biophys. Res. Comm., 210, 51, 10.1006/bbrc.1995.1626
Studier, 1990, Use of T7 RNA polymerase to direct expression of cloned genes, Methods Enzymol., 85, 60, 10.1016/0076-6879(90)85008-C
Teicher, 1994, Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other antiangiogenic agents, Int. J. Cancer, 57, 1, 10.1002/ijc.2910570624
Tolsma, 1993, Peptides derived from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic activity, J. Cell Biol., 122, 497, 10.1083/jcb.122.2.497